Sign in

CIK 0000744218

  • Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133191702
Phone
+1 908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 73 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-15 Crowley Elizabeth Sr. VP &CPDO Grant or award · Incentive Stock Option (right to buy) +82,000 82,000
2017-06-15 Davis Thomas Andrew Executive VP & CMO Grant or award · Incentive Stock Option (right to buy) +150,000 150,000
2017-06-15 KELER TIBOR Executive VP & CSO Grant or award · Incentive Stock Option (right to buy) +162,000 162,000
2017-06-15 Marucci Anthony S President & CEO Grant or award · Incentive Stock Option (right to buy) +475,000 475,000
2017-06-01 McMahon Gerald PhD Director Shares withheld for taxes −2,869 $2.83 $8K 225,822
2017-05-01 McMahon Gerald PhD Director Shares withheld for taxes −2,869 $3.33 $10K 228,691
2017-04-03 McMahon Gerald PhD Director Shares withheld for taxes −2,869 $3.61 $10K 231,560
2017-03-01 McMahon Gerald PhD Director Shares withheld for taxes −32,927 $3.54 $117K 234,429
2017-03-01 MARINO JAMES J Director Grant or award · Non-Qualified Stock Option (right to buy) +8,000 8,000
2016-12-14 LaVallee Theresa SVP, Reg.& Precision Medicine Grant or award · Incentive Stock Option (right to buy) +75,000 75,000
2016-12-14 McMahon Gerald PhD Director Grant or award · Non-Qualified Stock Otion (right to buy) +8,000 8,000
2016-09-02 CATLIN AVERY W Sr. VP & CFO Exercise or conversion +10,000 $2.80 $28K 83,586
2016-09-02 CATLIN AVERY W Sr. VP & CFO Exercise or conversion · Employee Stock Option (right to buy) −10,000 25,000
2016-09-02 KELER TIBOR Executive VP & CSO Purchase +3,000 $3.32 $10K 18,868
2016-06-08 Wright Richard M. Sr. VP & CCO Grant or award · Incentive Stock Option +75,000 75,000
2016-06-08 PEPIN RONALD Sr. VP & CBO Grant or award · Incentive Stock Option +67,000 67,000
2016-06-08 CATLIN AVERY W Sr. VP & CFO Grant or award · Incentive Stock Option +135,000 135,000
2016-06-08 Davis Thomas Andrew Executive VP & CMO Grant or award · Incentive Stock Option +157,000 157,000
2016-06-08 KELER TIBOR Executive VP & CSO Grant or award · Incentive Stock Option +162,000 162,000
2016-06-08 Marucci Anthony S President & CEO Grant or award · Incentive Stock Option +475,000 475,000

Page 19 of 32 · 629 trades